- Home
- ME vs OKYO Comparison
ME vs OKYO Comparison
Compare ME & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ME
- OKYO
- Stock Information
- Founded
- ME 2006
- OKYO 2007
- Country
- ME United States
- OKYO United Kingdom
- Employees
- ME N/A
- OKYO N/A
- Industry
- ME Precision Instruments
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ME Health Care
- OKYO Health Care
- Exchange
- ME Nasdaq
- OKYO Nasdaq
- Market Cap
- ME 40.0M
- OKYO 37.0M
- IPO Year
- ME N/A
- OKYO 2022
- Fundamental
- Price
- ME $1.82
- OKYO $1.49
- Analyst Decision
- ME Hold
- OKYO Strong Buy
- Analyst Count
- ME 1
- OKYO 1
- Target Price
- ME $9.40
- OKYO $7.00
- AVG Volume (30 Days)
- ME 466.4K
- OKYO 192.8K
- Earning Date
- ME 01-28-2025
- OKYO 03-25-2025
- Dividend Yield
- ME N/A
- OKYO N/A
- EPS Growth
- ME N/A
- OKYO N/A
- EPS
- ME N/A
- OKYO N/A
- Revenue
- ME $208,775,000.00
- OKYO N/A
- Revenue This Year
- ME $22.00
- OKYO N/A
- Revenue Next Year
- ME $17.31
- OKYO N/A
- P/E Ratio
- ME N/A
- OKYO N/A
- Revenue Growth
- ME N/A
- OKYO N/A
- 52 Week Low
- ME $1.34
- OKYO $0.81
- 52 Week High
- ME $12.76
- OKYO $1.90
- Technical
- Relative Strength Index (RSI)
- ME 37.81
- OKYO 71.84
- Support Level
- ME $1.48
- OKYO $1.14
- Resistance Level
- ME $1.75
- OKYO $1.45
- Average True Range (ATR)
- ME 0.17
- OKYO 0.12
- MACD
- ME 0.02
- OKYO 0.03
- Stochastic Oscillator
- ME 40.43
- OKYO 82.02
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.